Eli Lilly strikes $1.3 billion deal to buy gene-editing startup Verve Therapeutics, companies say Released2025-06-17 13:20 newsweb article Read more on www.cnbc.com E Picture from image.cnbcfm.com Related items Published byCCNBC In one list NewsNews345,146 items
